Additionally, ACT with SRC-3 KO Tregs markedly reduced Foxp3+ cells in breast tumors compared to ACT with WT Tregs (Fig. 5H and SI Appendix, Fig. S14E). Here, NCOA3 is linked to breast neoplasm.